Subscribe Now Subscribe Today
Science Alert
Curve Top
American Journal of Drug Discovery and Development
  Year: 2012 | Volume: 2 | Issue: 2 | Page No.: 87-100
DOI: 10.3923/ajdd.2012.87.100
Facebook Twitter Digg Reddit Linkedin StumbleUpon E-mail

Formulation and Evaluation of Simvastatin Injectable in situ Implants

G. Mownika and Prathima Srinivas

Simvastatin is anti-hyperlipidemic drug which is used to control elevated cholesterol or hypercholesterolemia. The drug undergoes extensive first pass metabolism and has a t1/2 of 3 h. It has poor bioavailability (about 5%) and high protein binding (>95%).The dosage form currently available is conventional uncoated tablet administered once daily. The objective of the present study was to improve the bioavailability of the drug by formulating an intraperitoneal implant and to sustain the drug release for atleast 15 days. The formulation was prepared by polymer precipitation method. In this method, the polymer drug solution is injected into the aqueous buffer from which the solvent dissipates into buffer and forms a solid implant. The optimized formulations were evaluated for drug content, cumulative percentage drug release, solvent ratio, surface morphology and drug interactions. From our studies, it was observed that the drug entrapment efficiency increased and the burst release decreased with increase in the polymer concentration. We could achieve sustained release of the drug with optimized formulation. The formulation with 20% polymer concentration exhibited moderate burst release and sustained release for 15 days. The in situ implants showed no drug polymer interactions. The SEM configurations showed polymer precipitation and the crosslinking of the polymer. Pharmacokinetic studies performed on rats confirmed sustained drug release up to 15 days. The bioavailability of the drug was also found to be improved and showed a 3 fold increase when compared to control tablets (ZOCOR 10 mg). Hence in addition to our studies, further research and clinical investigations can certainly help in proposing Simvastatin in situ implants as a treatment alternative in hyperlipidemic patients.
PDF Fulltext XML References Citation Report Citation
  •    Preparation and Evaluation of Gastroretentive Floating Pellets of Metronidazole Using Na-alginate and Hydroxyl Propyl Methyl Cellulose Polymers
  •    Copper Implantation in Lithium Niobate for Active Optical Waveguides
  •    A 16-electrode Fully Integrated and Versatile CMOS Microstimulator Dedicated to Cochlear Implant
  •    Studies of in vitro Evaluation and Formulation of Aceclofenac Loaded PLGA Microspheres
  •    Design of Wireless Power and Data Transmission Circuits for Implantable Biomicrosystem
How to cite this article:

G. Mownika and Prathima Srinivas, 2012. Formulation and Evaluation of Simvastatin Injectable in situ Implants. American Journal of Drug Discovery and Development, 2: 87-100.

DOI: 10.3923/ajdd.2012.87.100






Curve Bottom